Expression IRF/MUM1>25% Predictor to Three-year Survival of Diffuse Large B Cell Lymphoma in the Immunochemotherapy Era

INTRODUCTION: Non Hodgkin lymphoma-Diffuse large B cell lymphoma (DLBC) is composed of more varieties of one disease. Analysis and understanding of a wide range of characteristics of the disease, which include: clinical, immunohistochemical, cytogenetic and molecular characteristics may improve trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Sofo-Hafizovic, Alma, Chikha, Adisa, Gojak, Refet, Hadzimesic, Emina Suljovic
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AVICENA, d.o.o., Sarajevo 2016
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5136440/
https://www.ncbi.nlm.nih.gov/pubmed/27994293
http://dx.doi.org/10.5455/medarh.2016.70.342-347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5136440/
https://www.ncbi.nlm.nih.gov/pubmed/27994293
http://dx.doi.org/10.5455/medarh.2016.70.342-347

Ejemplares similares